Nvidia is turning its AI firepower toward the hardest problems in medicine, striking multibillion-dollar alliances with ...

Simulations Plus (NASDAQ:SLP) reported fiscal first-quarter 2026 results that management said came in line with internal ...

Q1 FY2026 earnings call recap: revenue $18.4M, guidance reaffirmed, services strength, AI rollout, mix outlook—read key insights.

Kanazawa University, in collaboration with Osaka University and the National Institutes for Quantum Science and Technology, ...

Guanidine is an organic compound primarily used as a denaturing reagent to disrupt the structures of proteins and nucleic ...

Noetik, an AI-native biotech company developing self-supervised machine learning and high-throughput spatial data to develop ...

Drug discovery costs have always been high. Nvidia claims its AI can reduce costs by 70%, backed by a $1B partnership with ...

Q1 2026 Earnings Call Transcript January 8, 2026 Simulations Plus, Inc. misses on earnings expectations. Reported EPS is ...

Defense Secretary Pete Hegseth says the Pentagon will deploy AI across classified networks as critics continue to warn about ...

Detailed price information for Simulations Plus Inc (SLP-Q) from The Globe and Mail including charting and trades.

January 12, 2026. Infinitusbio.AI, a U.S.-based Pharmatech company and creator of the proprietary Simulative AI Digital Cell Clone platform, and Oncovita, a Paris-based biotechnology company spun out ...

Bioprinting is rapidly moving from research labs into commercial reality, and it is reshaping how the pharmaceutical and ...